FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
SHSE:688273's FCF Yield % is ranked better than 54.44% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: -0.39
vs SHSE:688273: 0.22
Nanjing Medlander Medical Technology Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nanjing Medlander Medical Technology Co FCF Yield % Related Terms
Nanjing Medlander Medical Technology Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Medlander Medical Technology Co FCF Yield % Chart
Nanjing Medlander Medical Technology Co Annual Data
SHSE:688273 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Nanjing Medlander Medical Technology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Medlander Medical Technology Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Medlander Medical Technology Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Nanjing Medlander Medical Technology Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Medlander Medical Technology Co (SHSE:688273) has a FCF Yield % of 0.22 as of Jul. 05, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nanjing Medlander Medical Technology Co and its competitors. This is near median its historical median of 0.22. According to the industry distribution chart, Nanjing Medlander Medical Technology Co ranks #390 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 45.6%.
Is Nanjing Medlander Medical Technology Co's FCF Yield % too high?
Nanjing Medlander Medical Technology Co's current FCF Yield % of 0.22 is near median its 10-year median of 0.22. Based on the distribution chart, Nanjing Medlander Medical Technology Co ranks #390 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Medlander Medical Technology Co ranks #390 out of 856 companies for FCF Yield %. This puts Nanjing Medlander Medical Technology Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nanjing Medlander Medical Technology Co and its competitors. Nanjing Medlander Medical Technology Co's current FCF Yield % is 0.22, which is near median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥34.86, compared to a current price of ¥41.18 — trading 18.1% above its estimated fair value. The current FCF Yield % is 0.22, which is near median its 10-year median of 0.22. Nanjing Medlander Medical Technology Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current FCF Yield % is 0.22 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued.
The current stock price of ¥41.18 is trading 18.1% above its estimated GF Value™ of ¥34.86.
GuruFocus considers Nanjing Medlander Medical Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688273:
FCF Yield %: 0.22 (near median its 10-year median of 0.22)
GF Value™: ¥34.86 vs. price of ¥41.18 (18.1% above fair value)
No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Medlander Medical Technology Co Business Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
79GF Score
Get the complete analysis for SHSE:688273
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688273 has been successfully added to your 
